EC Mergers & Acquisitions Research
Advisory Approach
EC M&A is a premier global M&A advisory and merchant banking firm dedicated to serving industrial technology and life sciences companies worldwide. Founded in 1992 and headquartered in New York, EC M&A operates as an independent, specialized investment banking boutique with deep expertise in advising technology-driven industrial and life sciences businesses on merger, acquisition, and capital markets transactions. The firm's thesis is rooted in sector specialization: by focusing exclusively on industrial technology and life sciences sectors, EC M&A develops unparalleled domain expertise that translates into superior transaction outcomes for clients.
EC M&A's sweet spot is mid-market transactions in industrial technology and life sciences, particularly companies with enterprise values in the $50M to $1.5B+ range. The firm has particular strength advising both strategic buyers and financial sponsors (private equity, family offices) on transformational acquisitions, recapitalizations, divestitures, and majority stakes. Their positioning emphasizes institutional-quality process management combined with deep sector knowledge that enables them to unlock value in complex, technology-driven businesses where buyers and sellers often struggle to articulate true strategic value.
Global Presence and Scale
EC M&A operates across 11 offices and more than 70 M&A professionals spanning 3 continents, with primary hubs in New York, Chicago, London, and Frankfurt. The firm maintains a lean but highly specialized team structure: 20+ Managing Directors, Directors, and Vice Presidents supported by dedicated business development professionals. This global reach enables the firm to execute cross-border transactions and leverage relationships with international buyers and PE sponsors, particularly in Europe and North America.
The firm is fully FINRA-registered as a broker-dealer through EuroConsult Capital LLC and is authorized and regulated by the FCA in the UK, lending institutional credibility and enabling principal investment capabilities where appropriate.
Industrial Technology Sector Focus
EC M&A has completed 275+ industrial technology transactions across multiple subsectors. Within instrumentation and measurement, the firm has developed exceptional depth in test and measurement, analytical instruments, non-destructive testing (NDT) solutions, optics and photonics, and metrology and inspection systems. The firm also advises on industrial automation platforms, Industry 4.0 connectivity solutions, SCADA systems, and IoT technologies. Specialty materials and chemicals represent another key vertical, with expertise in advanced coatings, specialty additives, high-performance polymers, and engineered materials for aerospace and defense. EC M&A also maintains active practices in pumps, valves, and flow control systems for mission-critical industrial applications, plus energy and environmental sectors (oil and gas instrumentation, emissions monitoring, water treatment technologies).
Life Sciences & Medical Technologies Practice
EC M&A has completed 100+ life sciences transactions across bioprocessing, analytical instruments, medical devices and diagnostics, life science research tools, and pharmaceutical manufacturing equipment. The firm has particular expertise in single-use bioprocessing systems and purification technologies for cell and gene therapy manufacturing, which represents one of the fastest-growing subsectors. The firm also advises on chromatography systems, particle analyzers, spectroscopy equipment for research and quality control, non-invasive monitoring devices, breath analysis medical devices, and high-throughput cell sorting platforms.
Deal Track Record & Recent Activity
EC M&A has demonstrated consistent deal-making capability with significant recent transactions including the ESAB acquisition of Eddyfi Technologies for $1.45 billion in February 2026, representing a transformational entry into advanced NDT technologies. The firm also advised on Spectris' acquisition of Micromeritics Instrument Corporation for $630+ million, marking EC M&A's 12th transaction with Spectris. Additional major transactions include Investindustrial's acquisition of Proveris Scientific, Markes International's sale to Velaris (backed by Battery Ventures), optek-Danulat's acquisition by Crane, and The Churchill Companies' divestiture of Tekran to IEH Laboratories. EC M&A has become the #1 advisor in test, measurement, and control instrumentation M&A globally, as evidenced by founder Evan Yellin's personal leadership of 75+ completed transactions in this vertical alone. The firm's 275+ industrial technology transactions and 100+ life sciences transactions demonstrate deep institutional expertise and consistent access to both strategic and financial buyers.
Team Leadership
The firm is led by founders Hans C. Hornbostel and Evan Yellin, both Managing Directors with decades of M&A advisory experience spanning Europe and North America. Senior leadership includes Ryan Bloom, Managing Director with 20+ years advising industrial technology companies on M&A and capital markets solutions. Bloom brings exceptional credentials, including an MBA from Harvard Business School, and prior investment banking experience at Wells Fargo, Bank of America Merrill Lynch, and JPMorgan. The firm also includes former management consultants from McKinsey & Co. and experienced operators who understand the financial and strategic dynamics of industrial and life sciences businesses. The Managing Director roster spans 20+ experienced professionals ensuring continuity and institutional knowledge across all deal teams.
Buyer Network & Relationships
EC M&A maintains active relationships with major strategic acquirers in industrials, diversified manufacturers, and conglomerates (Spectris, ESAB, Crane, etc.), as well as leading private equity sponsors including Investindustrial, Battery Ventures, Genstar, and others. The firm's deal history demonstrates consistent success in accessing both strategic and financial buyer networks globally, with particular strength in European and North American PE relationships. The firm's founder Evan Yellin maintains particularly strong relationships in industrial technology PE, having closed dozens of transactions for PE-backed portfolio companies.
Process & Engagement Structure
EC M&A runs institutional-quality advisory processes combining exhaustive buyer outreach with sophisticated transaction management and commercial negotiation expertise. The firm offers both sell-side advisory (ranging from controlled processes to full auction structures) and buy-side advisory, as well as capital raising support for PE-backed portfolio companies seeking acquisitions. Typical engagements include comprehensive strategic advisory, vendor selection and due diligence support, transaction negotiation advisory, and post-close integration support. The firm works with both founder-owned and institutional shareholders, adapting process structure to client objectives and market conditions.
Competitive Positioning
EC M&A differentiates from larger, generalist investment banks through sector specialization, depth of domain expertise, and institutional M&A process discipline. Unlike full-service banks that treat industrial tech and life sciences as one of many practices, EC M&A has spent 34 years developing unparalleled expertise in these sectors. The firm's founders have completed hundreds of transactions each, providing judgment and risk management that newer or less-specialized advisors cannot match. The firm's global network of 70+ professionals enables local market expertise combined with access to global buyer networks. For sellers in industrial technology and life sciences, EC M&A represents the most specialized, focused advisor in the mid-market space.